Concepedia

Hidenori Namiki

HN

2

Publications

39

Citations

2

H-Index

2013

Active since

Affiliations

Daiichi-Sankyo (Japan)(Current)

Hidenori Namiki is an author at Daiichi-Sankyo (Japan) specializing in medicine, pharmacology, and cellular biochemistry.

Top concepts

MedicinePharmacologyApoptosisPathologyCell DeathBiochemistryCell BiologyTumor BiologyCancer TherapyDrug Discovery

Publications per year

2013–2022

2

Publications

2

Potent and Selective PTDSS1 Inhibitors Induce Collateral Lethality in Cancers with PTDSS2 Deletion

Yohei Yoshihama, Hidenori Namiki, Taiga Kato et al. · Cancer Research · 2022 · 27 citations

Apoptosis, Cell Death, Pathology +18

Lead optimization of 5-amino-6-(2,2-dimethyl-5-oxo-4-phenylpiperazin-1-yl)-4-hydroxyhexanamides to reduce a cardiac safety issue: Discovery of DS-8108b, an orally active renin inhibitor

Yuji Nakamura, Teppei Fujimoto, Yasuyuki Ogawa et al. · Bioorganic & Medicinal Chemistry · 2013 · 12 citations · Full text

Medicinal Chemistry, Cardiac Safety Issue, Biochemistry +12

Rows per page

1–2 of 2